Gene-gene interaction between apoa5 and usf1: Two candidate genes for the metabolic syndrome The KORA group

Obesity Facts

Volumn 2, Issue 4, 2009, Pages 235-242

  Singmann, Paula ^a   Baumert, Jens ^a   Herder, Christian ^b   Meisinger, Christa ^a   Holzapfel, Christina ^a,c   Klopp, Norman ^a   Wichmann, H Erich ^a,d   Klingenspor, Martin ^e   Rathmann, Wolfgang ^b   Illig, Thomas ^a   Grallert, Harald ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

APOA5; Cardiovascular risk; Metabolic syndrome; SNP; USF1

Indexed keywords

APOLIPOPROTEIN A5; LIPID; UPSTREAM STIMULATORY FACTOR 1;

ADULT; AGED; ALLELE; APOLIPOPROTEIN A5 GENE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATION PROGRAM; FEMALE; GENE; GENE INTERACTION; GERMANY; HEALTH SURVEY; HOMOZYGOSITY; HUMAN; LIPID BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UPSTREAM STIMULATORY FACTOR 1 GENE;

ADULT; AGED; APOLIPOPROTEINS A; CARDIOVASCULAR DISEASES; FEMALE; GERMANY; HOMOZYGOTE; HUMANS; MALE; METABOLIC SYNDROME X; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; SUPPRESSION, GENETIC; UPSTREAM STIMULATORY FACTORS;

EID: 70249150075     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000227288     Document Type: Article

References (26)

1. Candib LM: Obesity and diabetes in vulnerable populations: reflection on proximal and distal causes. Ann Fam Med 2007;5:547-556.
2. Shoulders CC, Naoumova RP: USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome. Trends Mol Med 2004; 10:362-365.
3. van der Vliet HN, Sammels MG, Leegwater AC, Levels JH, Reitsma PH, Boers W, Chamuleau RA: Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 2001;276:44512-44520.
4. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001;294:169-173.
5. Ribalta J, Figuera L, Fernandez-Ballart J, Vilella E, Castro CM, Masana L, Joven J: Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipide-mia. Clin Chem 2002;48:1597-1600.
6. Eichenbaum-Voline S, Olivier M, Jones EL, Naou-mova RP, Jones B, Gau B, Patel HN, Seed M, Bet-teridge DJ, Galton DJ, Rubin EM, Scott J, Shoulders CC, Pennacchio LA: Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2004;24:167-174.
7. Grallert H, Sedlmeier EM, Huth C, Kolz M, Heid IM, Meisinger C, Herder C, Strassburger K, Gehrin-ger A, Haak M, Giani G, Kronenberg F, Wichmann HE, Adamski J, Paulweber B, Illig T, Rathmann W: APOA5 variants and metabolic syndrome in Caucasians. J Lipid Res 2007;48:2614-2621.
8. Jakel H, Nowak M, Helleboid-Chapman A, Fruchart-Najib J, Fruchart JC: Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins? Ann Med 2006;38:2-10.
9. Pajukanta P, Lilja HE, Sinsheimer JS, Cantor RM, Lusis AJ, Gentile M, Duan XJ, Soro-Paavonen A, Naukkarinen J, Saarela J, Laakso M, Ehnholm C, Taskinen MR, Peltonen L: Familial combined hy-perlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet 2004;36:371-376.
10. Putt W, Palmen J, Nicaud V, Tregouet DA, Tahri-Daizadeh N, Flavell DM, Humphries SE, Talmud PJ: Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. Hum Mol Genet 2004;13:1587-1597.
11. Nowak M, Helleboid-Chapman A, Jakel H, Martin G, Duran-Sandoval D, Staels B, Rubin EM, Pennacchio LA, Taskinen MR, Fruchart-Najib J, Fruchart JC: Insulin-mediated down-regulation of apolipoprote-in A5 gene expression through the phosphatidyli-nositol 3-kinase pathway: role of upstream stimula-tory factor. Mol Cell Biol 2005;25:1537-1548.
12. Komulainen K, Alanne M, Auro K, Kilpikari R, Pajukanta P, Saarela J, Ellonen P, Salminen K, Ku-lathinal S, Kuulasmaa K, Silander K, Salomaa V, Perola M, Peltonen L: Risk alleles of USF1 gene predict cardiovascular disease of women in two prospective studies. PLoS Genet 2006;2:e69.
13. Holzapfel C, Baumert J, Grallert H, Müller A, Thorand B, Khuseyinova N, Herder C, Meisinger C, Hauner H, Wichmann H, Koenig W, Illig T, Klopp N: Genetic variants in the USF1 gene are associated with LDL cholesterol levels and incident T2DM in women: results from the MONICA/ KORA Augsburg case-cohort study, 1984-2002. Eur J Endocrinol 2008;159:407-416.
14. Holle R, Happich M, Lowel H, Wichmann HE: KORA - a research platform for population based health research. Gesundheitswesen 2005;67(suppl 1): S19-S25.
15. Wichmann HE, Gieger C, Illig T: KORA-gen - resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 2005;67(suppl 1):S26-S30.
16. Vollmert C, Windl O, Xiang W, Rosenberger A, Zerr I, Wichmann HE, Bickeboller H, Illig T, Kretzschmar HA: Significant association of a M129V independent polymorphism in the sporadic Creutzfeldt-Jakob disease in a large German case-control study. J Med Genet 2006;43:e53.
17. Guo SW, Thompson EA: Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992;48:361-372.
18. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109:433-438.
19. Moore JH, Williams SM: Traversing the conceptual divide between biological and statistical epista-sis: systems biology and a more modern synthesis. Bioessays 2005;27:637-646.
20. Talmud PJ, Palmen J, Putt W, Lins L, Humphries SE: Determination of the functionality of common APOA5 polymorphisms. J Biol Chem 2005;280: 28215-28220.
21. Prieur X, Huby T, Coste H, Schaap FG, Chapman MJ, Rodriguez JC: Thyroid hormone regulates the hy-potriglyceridemic gene APOA5. J Biol Chem 2005; 280:27533-27543.
22. Nowak M, Helleboid-Chapman A, Jakel H, Moitrot E, Rommens C, Pennacchio LA, Fruchart-Najib J, Fruchart JC: Glucose regulates the expression of the apolipoprotein A5 gene. J Mol Biol 2008;UTR of the PRNP gene with 380:789-798.
23. Naukkarinen J, Ehnholm C, Peltonen L: Genetics of familial combined hyperlipidemia. Curr Opin Li-pidol 2006;17:285-290.
24. Pessi T, Eklund C, Huhtala H, Raitakari OT, Juonala M, Kahonen M, Viikari JS, Lehtimaki T, Hurme M: CRP and FCGR2A genes have an epistatic effect on carotid artery intima-media thickness: the Cardiovascular Risk in Young Finns Study. Int J Immu-nogenet 2008;36:39-45.
25. Brisson D, St Pierre J, Santure M, Hudson TJ, Des-pres JP, Vohl MC, Gaudet D: Genetic epistasis in the VLDL catabolic pathway is associated with deleterious variations on triglyceridemia in obese subjects. Int J Obes (Lond) 2007;31:1325-1333.
26. Day C: Metabolic syndrome, or what you will: definitions and epidemiology. Diab Vasc Dis Res 2007; 4:32-38.